BioHarvest Sciences Inc. Quarterly Shareholder Update Live Event October 14, 2021, at 2:00pm E.T.
British Columbia and Rehovot, Israel--(Newsfile Corp. - October 12, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) (FSE: 8MV) ("BioHarvest" or the "Company") invites its shareholders and the general public to join a Live Video Conference ("Webinar") on Thursday, October 14, 2021, at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time). BioHarvest Sciences CEO Ilan Sobel will host the event, which will include a report on all major 2021 priorities, including a detailed performance...
2021-10-12 8:55 AM EDT
BioHarvest Sciences Inc Announces the Closing of Its Previously Announced Private Placement and the Amount Raised from Exercise of Warrants
British Columbia and Rehovot, Israel--(Newsfile Corp. - October 4, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") announces the closing of its second and final tranche of the private placement announced on August 4th, 2021. Under this private placement, the Company issued a total of 7,781,375 units ("each a Unit') for proceeds of CAD$ 3,501,619 with net proceeds of CAD$ 3,484,849 after payment of commissions and finders fees of CAD$ 16,770. Under the first...
2021-10-04 8:55 AM EDT
Bioharvest Sciences Inc. Announces Closing of the First Tranche of Its Private Placement
British Columbia and Rehovot, Israel--(Newsfile Corp. - August 30, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") is pleased to announce that it has closed the first tranche (the "First Tranche") of its non-brokered private placement (the "Private Placement") previously announced on August 4, 2021. Under the First Tranche, the Company has issued 6,845,368 units (each a "Unit") at $0.45 per Unit for gross proceeds of CAD$ 3,080,415.60, net CAD$ 3,066,850.60 after...
2021-08-30 8:55 AM EDT
BioHarvest Sciences Inc. Announces a CAD 4 Million Private Placement to Accelerate Its Cannabis Development Program and Production Capacity in Israel
British Columbia and Rehovot, Israel--(Newsfile Corp. - August 4, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") announces that its board of directors has approved a private placement (the "Offering") for up to 8,888,889 units at a price of CAD 0.45 (the "Offering Price") per unit for gross proceeds of up to CAD 4,000,000. Each unit will consist of one common share of the Company (a "Share") in the capital of the Company and one-half (1/2) of one share purchase...
2021-08-04 8:55 AM EDT
BioHarvest Sciences Inc. Shareholder Update - Live Event July 8, 2021, at 2:00pm E.T.
Vancouver, British Columbia--(Newsfile Corp. - July 2, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) (the "Company", "BioHarvest") invites its shareholders and the general public to join a Live Video Conference ("Webinar") on Thursday, July 8, 2021, at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time). BioHarvest Sciences CEO Ilan Sobel will host the event, which will include a report on all major 2021 priorities, including a performance update on Israel VINIA® Q2 results and the...
2021-07-02 9:47 AM EDT
BioHarvest Sciences Inc. Reveals VINIA Anti-Aging Capabilities via Blood Flow Improvement
Vancouver, British Columbia--(Newsfile Corp. - June 15, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") announces that its flagship VINIA® product is the only dietary supplement available in the US market which has the capability for both reducing the endothelin 1 (ET1) enzyme as well as increasing the nitric oxide (NO) molecules, in order to increase the dilation of arteries and thereby improve blood flow. The presence of ET1 constricts the blood vessel, whereas...
2021-06-15 8:05 AM EDT
BioHarvest Sciences Inc. Achieves Critical Milestones in the BioFarming of Cannabis
Vancouver, British Columbia--(Newsfile Corp. - June 8, 2021) - BioHarvest Sciences Inc. ("BioHarvest" or the "Company") (CSE: BHSC) announces today that it has successfully performed certain critical tasks necessary for the completion of its Cannabis development program. The Company has been adapting its unique and proprietary BioFarming technology, which enables the production of cannabinoids without growing the cannabis plant itself. Despite the many challenges caused by the Covid 19...
2021-06-08 8:55 AM EDT
BioHarvest Sciences Inc. Debuts Direct to Consumer Sales of Vinia in the United States
Vancouver, British Columbia--(Newsfile Corp. - May 12, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) (FSE: 8MV) ("BioHarvest" or the "Company") announces the launch of direct-to-consumer sales of its flagship product VINIA® in the United States, via its vinia.com website. After years of developing its BioFarming technology, the company is proud to bring the first product based on this technology to the US market. VINIA® is the first and only product in the world containing Piceid Resveratrol...
2021-05-12 8:55 AM EDT
BioHarvest Sciences Inc. to Launch E-Commerce Sales of VINIA in the United States on May 12, 2021
Vancouver, British Columbia--(Newsfile Corp. - May 6, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") announces that online sales of its flagship VINIA® product in the United States will commence at 8 A.M. Eastern Time on May 12, 2021, via its vinia.com website. This milestone represents a turning point for BioHarvest as it brings its flagship product to the United States, the largest market in the world for nutraceutical supplements. VINIA® is a product anchored...
2021-05-06 8:55 AM EDT
BioHarvest Sciences Inc. Delivers Record First Quarter Sales Performance of VINIA in Israel
Vancouver, British Columbia--(Newsfile Corp. - April 7, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") announced today that sales orders of VINIA® in Q1/2021 reached an all-time high of US$ 377,756, representing a 17% increase over Q4/2020 sales orders, and a 668% increase over Q1/2020. The total number of VINIA® purchase orders in Q1/2021 also reached a new high of 2,190, an increase of 45% versus Q4/2020. The results in the Israeli market, with a relatively...
2021-04-07 8:55 AM EDT
BioHarvest Sciences Inc. Shareholder Update - Live Event April 8, 2021 at 2:00pm E.T.
Vancouver, British Columbia--(Newsfile Corp. - March 31, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) (the "Company", "BioHarvest") invites its shareholders and the general public to join a Live Video Conference ("Webinar") on Thursday, April 8, 2021 at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time). BioHarvest Sciences CEO Ilan Sobel will host the event, which will include a look forward to the imminent e-commerce launch for VINIA® in the United States, a review of Q1 2021...
2021-03-31 10:42 AM EDT
BioHarvest Sciences Inc. Adds Global Marketing Expert Scott McCune to Advisory Board
Vancouver, British Columbia--(Newsfile Corp. - March 25, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) (the "Company", "BioHarvest") announces the appointment of Scott McCune to its Board of Advisors. With the appointment of Scott, a highly experienced marketing professional, BioHarvest has succeeded in assembling a best-in-class team of expert advisors to cover all the major aspects of the company's business. Scott will leverage his experience to assist the BioHarvest team in building a...
2021-03-25 8:55 AM EDT
BioHarvest Sciences Inc. Receives Approval from Israel's Ministry of Health to Include VINIA in a Health Snack Bar
Vancouver, British Columbia--(Newsfile Corp. - March 18, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") has received approval from the Ministry of Health in Israel to include VINIA®, its proprietary red grape cell product, in a health snack bar. This is an important development for BioHarvest as it introduces the Company's innovative and highly differentiated product into the lucrative multibillion-dollar snack bar market. The product will initially be launched...
2021-03-18 8:55 AM EDT
BioHarvest Sciences Inc. Announces Listing on Frankfurt Stock Exchange
Vancouver, British Columbia--(Newsfile Corp. - March 10, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") announces that it is now trading on the Frankfurt Stock Exchange. BioHarvest Sciences Inc. is now listed on the Frankfurt Stock Exchange (also known as the Deutsche Boerse AG) under WKN: A2P3RM and the symbol 8MV. The company's shares continue to be listed on the Canadian Securities Exchange under the symbol C.BHSC. The Frankfurt listing will increase the...
2021-03-10 8:55 AM EST
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
Vancouver, British Columbia--(Newsfile Corp. - March 4, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and...
2021-03-04 8:55 AM EST
BioHarvest Sciences Inc. Announces Partnership with BOLDT and Summit Strategy Group to Develop a Sustainability Framework and ESG Report
Vancouver, British Columbia--(Newsfile Corp. - February 16, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") announces that it has entered into a partnership with BOLDT AG, an international business strategy and communications consultancy based in Europe, and Summit Strategy Group LLC, a U.S.-based communications firm, to develop BioHarvest's global sustainability strategy and ESG reporting framework. Both firms have deep experience working with purpose-driven...
2021-02-16 8:55 AM EST
BioHarvest Sciences Inc. Announces a Major Breakthrough in the Growth of Cannabis TRICHOMES across Multiple Strains in Liquid Media
Vancouver, British Columbia--(Newsfile Corp. - February 9, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") announces that it is now able to consistently grow Trichomes from multiple cannabis plant strains, in liquid media. Furthermore, BioHarvest is the world's first and only Company to successfully develop the proprietary knowledge required to control the production of cannabis cells in liquid media, and has now developed the unique know-how to optimize the...
2021-02-09 8:55 AM EST
BioHarvest Sciences Inc. Signs an Exclusive Agreement with Cukierman & Co. Life Sciences to Explore Pharmaceutical Partnerships for the Use of VINIA(R) as an Adjuvant Therapy in Type 2 Diabetes Treatments
Vancouver, British Columbia--(Newsfile Corp. - February 4, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") announces that it has signed a financial advisory agreement with Cukierman & Co. Investment House Ltd., a full service Israeli financial advisory firm with life sciences expertise and global capabilities, granting it a mandate to explore opportunities for the application of VINIA® as an adjuvant therapy in the treatment of type 2 diabetes patients. The...
2021-02-04 8:55 AM EST
BioHarvest Sciences Inc. Announces Closing of Oversubscribed Private Placement. Company Issues 15,449,829 Units at $0.40 per Unit for Gross Proceeds of $6,179,931.60
Vancouver, British Columbia--(Newsfile Corp. - February 2, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) (the "Company", or "BioHarvest") announces that it has closed its private placement of units at $0.40 per unit previously announced on January 21, 2021. The private placement was oversubscribed by 449,829 units and the Company has determined to accept the oversubscriptions. A total of 15,449,829 units at $0.40 per unit were issued, for gross proceeds of $6,179,932. Net proceeds after...
2021-02-02 2:08 PM EST
BioHarvest Sciences Inc. Announces Private Placement
Vancouver, British Columbia--(Newsfile Corp. - January 21, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company"). The Company announced today that its board of directors have approved a private placement of up to 15,000,000 units at a price of $.40 per unit for gross proceeds of up to $6,000,000. Each unit will consist of one common share of the Company and one share purchase warrant. Each share purchase warrant will be exercisable to purchase an additional common share...
2021-01-21 8:55 AM EST